HH-2853

CAT: 0931-T202024-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-T202024-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2202678-04-2
Bioactivity
HH-2853 is a potent inhibitor targeting EZH1/2, demonstrating significant antitumor activity. Its IC50 values for both wild-type and mutant EZH2 range from 2.21-5.36 nM, comparable to tazemetostat. HH-2853 is more effective against EZH1, with an IC50 of 9.26 nM, notably lower than tazemetostat's 58.43 nM. However, at concentrations up to 10 ?M, it exhibits minimal inhibitory activity on 36 types of histone-modifying enzymes. On the cellular level, HH-2853 effectively inhibits mono-, di-, and tri-methylation of H3K27 in various cancer cell lines with wild-type or mutant EZH2, without affecting other methylation types on histone H3 at concentrations up to 10 ?M. Additionally, HH-2853 significantly reduces cell viability in multiple cancer cell lines carrying EZH2 GOF mutations or SWI/SNF complex alterations, and demonstrates superior antitumor effects compared to tazemetostat in several tumor xenograft models at equivalent doses.
Smiles
O=C(NCC=1C(=O)NC(=CC1OC)C)C2=CC3=C(C=CN3C(=C2C)C(N4CCN(CC4)CC(F)(F)F)C)C5=NN=C(C=C5)C
Molecular Formula
C31H36F3N7O3
Molecular Weight
611.66
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T11825-01LCB-2853
T202649-01Lcb 2853
T24754-01Hh-Ag1.5
T32075HH-Folic acid
T34548-01SC 28538
T9901A-810-01TQB-2858
T10533-01BI-2852
T9254-01TP-2857
T72084-01(R) -BI-2852
T207778-01BI 2852 FL

Alternative Products

CatalogName
MBS5766975LCB-2853
A19790-10LCB-2853 10mg
A19790-50LCB-2853 50mg
A19790-5LCB-2853 5mg
A19790-1LCB-2853 1mg
HY-101700ALCB 2853 (sodium)
ARC0296HH
M34022-01Hh-Ag1.5
MBS5781657HH-Folic acid
HY-107551-01Hh Pathway-IN-1

Popular Products